Follow Centile Bio’s latest scientific progress, research milestones, collaborations, and company updates as we continue advancing quantitative neuroscience.
Featured
Publications
Brain Charts for the Human Lifespan
Population brain charts from 123,984 MRI scans spanning prenatal development to age 100, enabling individual centile scoring of brain structure.
dGAMLSS enables exact population brain chart model fitting across multiple institutions without sharing patient-level data, removing the privacy barrier to federated multi-site clinical deployment of brain charting
From Scanner to Science: Converting Clinical Brain MRI into Research-Ready Data
An end-to-end informatics workflow converts routine clinical brain MRI from PACS extraction through de-identification and processing into research-ready data, demonstrating the operational infrastructure for unlocking imaging archives at scale.
ComBatLS removes scanner site effects from brain MRI while preserving age and sex variance, improving normative score accuracy across diverse clinical sites.
Oops! Something went wrong while submitting the form.
News
Leadership Spotlight: Dr. Josh Bernstock, Co-Founder and CMO, Centile Bio
Josh Bernstock, MD, PhD, MPH, a neurosurgeon-scientist and entrepreneur affiliated with Texas Children’s Hospital, Baylor College of Medicine, and MD Anderson, is one of Centile Bioscience's co-founders. As Chief Medical Officer, he guides the company's clinical direction, ensuring its technology delivers practical value in clinical care, drug development, and research.
Diagnostics and Health-Economics Leader Hannah Mamuszka Joins Centile as Strategic Advisor
Hannah Mamuszka, a health-economics leader and diagnostics expert, joined Centile Bioscience's Advisory Board, where she guides the company's market-access, reimbursement, and health-economics strategy as Centile's platform moves toward clinical and commercial use.
The Award-Winning Science Behind Centile Bioscience
Centile Bioscience was founded to carry a body of award-winning brain science into practice. Its founding research, "Brain charts for the human lifespan," was published in Nature and won the inaugural FASEB/NIH DataWorks! Grand Prize, one of only two Grand Prize awards selected from more than 100 competing research groups nationwide.
TissUnet: Extracranial Tissue Segmentation from MRI Across All Ages
TissUnet extends quantitative MRI analysis beyond the brain, segmenting skull bone, subcutaneous fat, and muscle from routine T1-weighted scans across all ages and pathologies, achieving an 89% acceptance rate in healthy and brain tumor cohorts.
Charting Brain Asymmetry Across the Human Lifespan
The first population framework for brain asymmetry from prenatal to age 102 provides new benchmarks for neuropsychiatric and neurodegenerative research.
Deep Learning CT Brain Segmentation Validated in Aging and Dementia Cohorts
Next-generation 3D deep learning CT brain segmentation models outperform prior methods, validated across cognitively normal and dementia patient cohorts.
Deep Learning De-identification for Privacy-Safe Pediatric Brain MRI Sharing
A deep learning defacing model removes facial features from pediatric brain MRI with minimal research impact, enabling privacy-preserving clinical data reuse at scale.
Brain Charting Reveals Distinct Neurobiology in Autism and ADHD
Normative brain charting reveals distinct neuroanatomy in autism and ADHD, including sex differences often missed, supporting individual-level characterization.
A Lifespan-Generalizable Skull-Stripping Model for Brain MRI
An atlas-guided skull-stripping model validated on 21,334 scans from 18 sites generalizes across all ages, scanner types, and imaging protocols, enabling reliable brain volumetry on diverse clinical archives.
Large Samples and Longitudinal Design Drive Neuroimaging Replicability
Large sample sizes and longitudinal study design are the features that most reliably produce replicable neuroimaging findings, providing a scientific foundation for population-scale brain charting.
Centile Bio Advances Quantitative Brain Modeling Through Large-Scale Neuroimaging Analysis
Centile Bio has announced a new milestone in its ongoing effort to develop quantitative reference frameworks for understanding the human brain. By integrating large-scale neuroimaging datasets with advanced statistical modeling, the company continues to expand the scientific tools available for studying brain structure, variation, and disease progression. The work contributes to a growing body of research focused on improving how neurological changes are measured across populations and throughout the human lifespan.
CT Brain Volumetry Identifies Normal Pressure Hydrocephalus
Deep learning extracts brain volumetric biomarkers from routine head CT with accuracy comparable to MRI, making population-scale neurodegeneration screening viable without specialist imaging.
An invited commentary mapping the clinical and research applications of normative brain charting, from individualized medicine and early detection to trial enrichment, rare disease phenotyping, and longitudinal monitoring.
Brain Charting Captures Genetic Risk for Psychiatric Disorders
Copy Number Variant Risk Scores Associated With Cognition, Psychopathology, and Brain Structure in Youths in the Philadelphia Neurodevelopmental Cohort